deltatrials
Completed EARLY_PHASE1 INTERVENTIONAL 3-arm NCT02873299

High-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in PTSD (rTMS)

High-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in Post Traumatic Stress Disorder

Sponsor: United States Naval Medical Center, San Diego

Conditions PTSD, Post Traumatic Stress Disorder
Interventions 10 Hz rTMS of the right dorsolateral prefrontal cortex 20 Hz rTMS of the right dorsolateral prefrontal cortex
Updated 7 times since 2017 Last updated: Aug 18, 2016 Started: Apr 30, 2012 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on PTSD, Post Traumatic Stress Disorder, this trial is completed. The trial is conducted by United States Naval Medical Center, San Diego and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Study Description(click to expand)

This is a randomized single-blind pilot study investigating the efficacy of high-frequency repetitive transcranial magnetic stimulation (rTMS) applied to the right dorsolateral prefrontal cortex at either 10 Hz or 20 Hz as compared to a treatment as usual group for the treatment of Post Traumatic Stress Disorder (PTSD) symptoms.

This is a randomized single-blind pilot study investigating the efficacy of high-frequency repetitive transcranial magnetic stimulation (rTMS) applied to the right dorsolateral prefrontal cortex at either 10 Hz or 20 Hz as compared to a treatment as usual group for the treatment of Post Traumatic Stress Disorder (PTSD) symptoms.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted~Jan 2026 – present · 3 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Jan 2026 — Present [monthly]

    Completed EARLY_PHASE1

  2. Sep 2024 — Present [monthly]

    Completed EARLY_PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Completed EARLY_PHASE1

  5. Jun 2018 — Jan 2021 [monthly]

    Completed EARLY_PHASE1

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Completed EARLY_PHASE1

    Phase: Phase 0 → EARLY_PHASE1

  2. Jan 2017 — Feb 2017 [monthly]

    Completed Phase 0

    First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • United States Naval Medical Center, San Diego
Data source: United States Naval Medical Center, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations